95 related articles for article (PubMed ID: 15655454)
1. Intravitreal injection of VEGF siRNA.
Maguire MG; Fine SL; Ying GS
Retina; 2005 Jan; 25(1):101-2. PubMed ID: 15655454
[No Abstract] [Full Text] [Related]
2. Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization.
Tolentino MJ; Brucker AJ; Fosnot J; Ying GS; Wu IH; Malik G; Wan S; Reich SJ
Retina; 2004 Feb; 24(1):132-8. PubMed ID: 15076954
[TBL] [Abstract][Full Text] [Related]
3. Re: Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization.
Tolentino MJ; Brucker AJ; Wan S; Reich SJ; Gordon J; Duh YJ
Retina; 2004 Aug; 24(4):661. PubMed ID: 15300107
[No Abstract] [Full Text] [Related]
4. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
6. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of choroidal neovascularization by adenovirus-mediated delivery of short hairpin RNAs targeting VEGF as a potential therapy for AMD.
Cashman SM; Bowman L; Christofferson J; Kumar-Singh R
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3496-504. PubMed ID: 16877421
[TBL] [Abstract][Full Text] [Related]
8. PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression.
Zhu M; Liu X; Wang S; Miao J; Wu L; Yang X; Wang Y; Kang L; Li W; Cui C; Chen H; Sang A
Mol Vis; 2016; 22():1361-1374. PubMed ID: 27994435
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor-gamma ligands inhibit choroidal neovascularization.
Murata T; He S; Hangai M; Ishibashi T; Xi XP; Kim S; Hsueh WA; Ryan SJ; Law RE; Hinton DR
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2309-17. PubMed ID: 10892878
[TBL] [Abstract][Full Text] [Related]
10. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.
Krzystolik MG; Afshari MA; Adamis AP; Gaudreault J; Gragoudas ES; Michaud NA; Li W; Connolly E; O'Neill CA; Miller JW
Arch Ophthalmol; 2002 Mar; 120(3):338-46. PubMed ID: 11879138
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW
Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
[TBL] [Abstract][Full Text] [Related]
12. Angiography of fluoresceinated anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization.
Tolentino MJ; Husain D; Theodosiadis P; Gragoudas ES; Connolly E; Kahn J; Cleland J; Adamis AP; Cuthbertson A; Miller JW
Arch Ophthalmol; 2000 Jan; 118(1):78-84. PubMed ID: 10636419
[TBL] [Abstract][Full Text] [Related]
13. Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates.
Nork TM; Dubielzig RR; Christian BJ; Miller PE; Miller JM; Cao J; Zimmer EP; Wiegand SJ
Arch Ophthalmol; 2011 Aug; 129(8):1042-52. PubMed ID: 21825187
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate.
Tolentino MJ; Miller JW; Gragoudas ES; Chatzistefanou K; Ferrara N; Adamis AP
Arch Ophthalmol; 1996 Aug; 114(8):964-70. PubMed ID: 8694732
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization.
Zhao M; Xie W; Tsai SH; Hein TW; Rocke BA; Kuo L; Rosa RH
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1125-1133. PubMed ID: 29490350
[TBL] [Abstract][Full Text] [Related]
16. Blockage of tissue factor ameliorates the lesion of laser-induced choroidal neovascularization in mice.
Wang L; Yang Z; Yu Y; Cui C; Guan H; Chen H
Exp Eye Res; 2014 Oct; 127():117-23. PubMed ID: 25063201
[TBL] [Abstract][Full Text] [Related]
17. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
[TBL] [Abstract][Full Text] [Related]
18. Anti-VEGF PolysiRNA Polyplex for the Treatment of Choroidal Neovascularization.
Lee J; Ryoo NK; Han H; Hong HK; Park JY; Park SJ; Kim YK; Sim C; Kim K; Woo SJ; Park KH; Kim H
Mol Pharm; 2016 Jun; 13(6):1988-95. PubMed ID: 27173745
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of choroidal neovascularization by intravitreal ketorolac.
Kim SJ; Toma HS
Arch Ophthalmol; 2010 May; 128(5):596-600. PubMed ID: 20457981
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TRAF6 alleviates choroidal neovascularization in vivo.
Ding D; Zhu M; Liu X; Jiang L; Xu J; Chen L; Liang J; Li L; Zhou T; Wang Y; Shi H; Yuan Y; Song E
Biochem Biophys Res Commun; 2018 Sep; 503(4):2742-2748. PubMed ID: 30103950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
